Skip to content
Screener

Total Revenue at other companies

CVS Health logo
CVS HealthCVS
$106.1B+7.3%
Amazon logo
AmazonAMZN
$200.61B+19.6%
Doximity logo
DoximityDOCS
$156.62M+7.3%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$796.2M+9.9%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$3.61B+25.6%
Cencora logo
CencoraCOR
$84.75B+5.1%

Segments

By product

See full
Pharma manufacturer solutions revenue$151.38M
Prescription transactions revenue$106.39M-25.6%
Pharma Direct revenue$61.63M+76.2%
Subscription revenue$28.51M+39.3%
Other revenue$3.88M-15.0%

Other financials

Income statement

See full
Gross profit$179.4M-5.4%
Operating income$23.6M-11.9%
Net income$8.5M-33.5%
EPS (diluted)$0.02-50.0%

Balance sheet

See full
Cash & equivalents$296.1M+5.3%
Total debt$539.0M-1.6%
Total equity$647.6M+0.7%
Total assets$2.3B+77.7%

Cash flow

See full
Operating cash flow$80.8M+63.0%
CapEx$362.0K-7.2%
Free cash flow$80.5M+63.6%

Valuation

See full
Market cap$1.27B-18.1%
Enterprise value$1.51B-16.8%
P/E78.1×+33.3×
P/S1.6×-0.3×

Profitability

See full
Gross margin90.8%-2.8pp
Operating margin9.5%-1.6pp
Net margin2.1%-2.3pp
FCF margin25.1%+1.4pp

Returns & leverage

See full
Return on equity2.5%-2.8pp
Debt / equity0.8×0.0×
Current ratio1.4×-2.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001809519-26-000152
(in thousands, except for per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$200,411$203,070$394,417$406,040
Costs and operating expenses:
Cost of revenue, exclusive of depreciation and amortization presented separately below20,99913,35041,15526,714
Product development and technology26,71129,93356,88861,075
Sales and marketing81,98684,870163,039169,412
General and administrative24,81428,37951,63358,009
Depreciation and amortization22,26919,72944,06140,641
Total costs and operating expenses176,779176,261356,776355,851

Item 1. Financial Statements

FAQ

What is GoodRx Holdings, Inc.'s total revenue?
GoodRx Holdings, Inc. (GDRX) reported total revenue of $200.41M in Q2 2026.
How has GoodRx Holdings, Inc.'s total revenue changed year-over-year?
GoodRx Holdings, Inc.'s total revenue decreased by 1.3% year-over-year, from $203.07M to $200.41M.
What is the long-term trend for GoodRx Holdings, Inc.'s total revenue?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s total revenue has grown at a 1.7% compound annual growth rate (CAGR), from $745.42M to $796.85M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about GoodRx Holdings, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude